Symptom clusters during the late menopausal transition stage: Observations from the Seattle Midlife Women's Health Study

Menopause

Volumn 17, Issue 5, 2010, Pages 972-977

  Cray, Lori ^a,b   Woods, Nancy Fugate ^a   Mitchell, Ellen Sullivan ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b SEATTLE UNIVERSITY   (United States)

Author keywords

Cluster analysis; Menopause; Menopause transition; Symptom clusters

Indexed keywords

ESTRONE GLUCURONIDE; FOLLITROPIN; HYDROCORTISONE;

ADULT; AGE; ALCOHOL CONSUMPTION; ARTHRALGIA; ARTICLE; BODY MASS; CLIMACTERIUM; CONTROLLED STUDY; DISEASE SEVERITY; EXERCISE; FEMALE; HOT FLUSH; HUMAN; JOB STRESS; MAJOR CLINICAL STUDY; MENOPAUSAL SYNDROME; MOOD CHANGE; SLEEP DISORDER; SMOKING HABIT;

ARTHRALGIA; CLUSTER ANALYSIS; ESTRONE; FEMALE; FOLLICLE STIMULATING HORMONE; HOT FLASHES; HUMANS; HYDROCORTISONE; MENTAL FATIGUE; MIDDLE AGED; MOOD DISORDERS; PERIMENOPAUSE; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SLEEP INITIATION AND MAINTENANCE DISORDERS; STRESS, PSYCHOLOGICAL; WASHINGTON;

EID: 77957706013     PISSN: 10723714     EISSN: None     Source Type: Journal    
DOI: 10.1097/gme.0b013e3181dd1f95     Document Type: Article

References (33)

1. Utian WH. Psychosocial and socioeconomic burden of vasomotor symptoms in menopause: a comprehensive review. Health Qual Life Outcomes 2000;3:47.
2. Wilbur J, Miller AM, McDevitt J, Wang E, Miller J. Menopausal status, moderate-intensity walking, and symptoms in mid-life women. Res Theory Nurs Pract 2005;19:163-180.
3. Woods NF, Mitchell ES. Symptoms during the perimenopause: prevalence, severity, trajectory, and significance in women's lives. Am J Med 2005;118:S14-S24.
4. Maartens LWF, Knottnerus JA, Pop VJ. Menopausal transition and increased symptomatology: a community based prospective study. Maturitas 2002;42:195-200.
5. McMillan TL, Mark S. Complementary and alternative medicine and physical activity for menopausal symptoms. J Am Med Womens Assoc 2004;59:270-277.
6. Nedrow A, Miller J, Walker M, Nygren P, Huffman LH, Nelson HD. Complementary and alternative therapies for the treatment of menopause-related symptoms. Arch Intern Med 2006;166:1453-1465.
7. Santoro N, Sherman S. New interventions for menopausal symptoms: meeting summary. National Institute on Aging in collaboration with: National Institute of Child and Human Development, National Institute of Mental Health, National Center for Alternative and Complementary Medicine, NIH Office of Research on Women's Health, NIH of Dietary Supplements. Bethesda, MD: July 11-12, 2006, and November 20-21, 2006.
8. Writing Group for the Women's Health Initiative. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative Randomized Controlled Trial. JAMA 2002;288:321-333.
9. Avis NE, Brockwell S, Colvin A. A universal syndrome? Am J Med 2005;118:S37-S46.
10. Woods NF, Smith-DiJulio K, Percival DB, Tao EY, Taylor HJ, Mitchell ES. Symptoms during the menopausal transition and early post-menopause and their relation to endocrine levels over time: observations from the Seattle Midlife Women's Health Study. J Womens Health 2007; 16:667-677.
11. Woods NF, Smith-DiJulio K, Percival DB, Tao EY, Mariella A, Mitchell ES. Depressed mood during the menopausal transition and early postmenopause: observations from the Seattle Midlife Women's Health Study. Menopause 2008;15:223-232.
12. Mitchell ES, Woods NF. Symptom experiences of midlife women: observations from the Seattle Midlife Women's Health Study. Maturitas 1996;25:1-10.
13. Sherman S. Defining the menopausal transition. Am J Med 2005;118: S3-S7.
14. Santoro N. The menopausal transition. Am J Med 2005;118:S8-S13.
15. Mitchell ES, Woods NF, Mariella A. Three stages of the menopausal transition: toward a more precise definition. Menopause 2000;7:334-349.
16. Soules MR, Sherman S, Parrott E, et al. Stages of Reproductive Aging Workshop (STRAW). J Womens Health Gend Based Med 2001;10: 843-848.
17. Harlow SD, Mitchell ES, Crawford S, Nan B, Little R, Taffe J. The ReSTAGE Collaboration: defining optimal bleeding criteria for onset of early menopausal transition. Fertil Steril 2007;89:129-140.
18. Harlow SD, Cain K, Crawford S, et al. Evaluation of four proposed bleeding criteria for the onset of late menopausal transition. J Clin Endocrinol Metab 2006;91:3432-3438.
19. Gold EB, Block G, Crawford S, et al. Lifestyle and demographic factors in relation to vasomotor symptoms: baseline results from the Study of Women's Health Across the Nation. Am J Epidemiol 2004;159:1189-1199.
20. Denari JH, Farinati Z, Casas PRF, Oliva A. Determination of ovarian function using first morning urine steroid assays. Obstet Gynecol 1981; 58:5-9.
21. Stanczyk FZ, Miyakawa I, Goebelsmann U. Direct radioimmunoassay of urinary estrogen and pregnanediol glucuronides during the menstrual cycle. Am J Obstet Gynecol 1980;137:443-450. (Pubitemid 10073187)
22. O'Connor KA, Brindle E, Shofer JB, et al. Statistical correction for non-parallelism in a urinary enzyme immunoassay. J Immunoassay Immuno-chem 2004;25:259-278.
23. Lasley BL, Shidleler SE. Methods for evaluating reproductive health of women. Occup Med 1994;9:423-433.
24. Wilcox AJ, Baird DD, Weinberg CR, et al. The use of biochemical assays in epidemiologic studies of reproduction. Environ Health Perspect 1987; 75:29-35.
25. Robard D. Statistical quality control and routine data processing for ra-dioimmunoassays and immunoradiometric assays. Clin Chem 1974;20: 1255-1270.
26. Woods N, Carr MC, Tao EY, Taylor HJ, Mitchell ES. Increased urinary cortisol levels during the menopause transition. Menopause 2006;13: 212-221.
27. Muthén BO. Beyond SEM: general latent variable modeling. Behavior-metrika 2002;29:81-117.
28. Burr JA, Mutchler JE, Caro FG. Productive activity clusters among middle-aged and older adults: intersecting forms and time commitments. J Gerontol B Psychol Sci Soc Sci 2007;62:S267-S275.
29. Shevlin M, Murphy J, Dorahy MJ, Adamson G. The distribution of positive psychosis-like symptoms in the population: a latent class analysis of the National Comorbidity Survey. Schizophr Res 2007;89:101-109.
30. Muthen B, Muthen LK. Integrating person-centered and variable-centered analyses: growth mixture modeling with latent trajectory classes. Alcohol Clin Exp Res 2000;24:882-891.
31. Muthén LK, Muthén BO. Mplus User's Guide. 5th ed. Los Angeles, CA: Muthén & Muthén, 2007.
32. Miaskowski C, Cooper BA, Paul SM, et al. Subgroups of patients with cancer with different symptom experiences and quality-of-life outcomes: a cluster analysis. Oncol Nurs Forum 2006;33:E79-E89.
33. Hall JE. Neuroendocrine changes with reproductive aging in women. Semin Reprod Med 2007;25:344-351.